Purchase Order N3239823P0347
Award Date 8/21/23
Potential Completion Date 8/25/23
Potential Value $15K
Federal Agency
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20910, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of the Navy Bureau of Medicine and Surgery awarded a $15,000 firm fixed price purchase order to Becton, Dickinson and Company BD Biosciences, Systems and Reagents Division for preventive maintenance services on a flow cytometer. As the prime contractor, BD Biosciences will perform the requested yield services to maintain functionality of the medical device equipment. The Bureau of Medicine and Surgery supports Navy and Marine Corps medical readiness through programs such as...
- The U.S. Department of the Navy's Bureau of Medicine and Surgery (BUMED) awarded a $47,886.84 firm fixed-price purchase order contract to Becton, Dickinson and Company (BD) to provide maintenance services for a BD LSRFortessa flow cytometry instrument and associated equipment. The contract has a period of performance from September 27, 2024 to September 26, 2025, with two scheduled preventive maintenance visits per year. This sole-source award is not set aside and is being procured under FAR...
- The U.S. Navy Bureau of Medicine and Surgery awarded a $107,915 firm fixed price purchase order to Becton, Dickinson and Company (BD), through its BD Biosciences division, for maintenance services on a BD LSR Fortessa flow cytometer located in San Antonio, Texas. This award represents the second renewal year of the maintenance contract for the specific instrument (Serial Number H64955800120, ECN 98471), with an ultimate completion date of September 22, 2028. The contract was awarded without a...
- The Naval Medical Research Command has awarded a firm fixed-price purchase order valued at $49,409.64 to Becton, Dickinson and Company (BD), through its BD Biosciences division, for preventive maintenance and repair services on a BD LSRFortessa flow cytometer located at the command's facility in Silver Spring, Maryland. The contract was awarded on September 27, 2025, with an ultimate completion date of September 26, 2026, with no small business set-aside designation. BD Biosciences is the...
- Becton, Dickinson and Company, through its BD Biosciences division, was awarded a firm fixed-price purchase order valued at $88,457.40 by the Bureau of Medicine and Surgery (a Defense agency component) on November 1, 2025, for maintenance services on FACSymphony A1 flow cytometry instruments and FACS Flow Supply System equipment. The contract specifies two instrument configurations identified by catalog model numbers and serial numbers, with an ultimate completion date of October 31, 2030,...
- Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, received a $5,000 firm fixed price purchase order from the Bureau of Medicine and Surgery (Naval Medical) for repair services, with an ultimate completion date of May 29, 2015. This non-set-aside contract was awarded on April 29, 2015 and will be performed in San Jose, California. BD Biosciences specializes in providing sophisticated flow cytometry instruments, cell imaging technologies, reagents, and...
- This is a delivery order contract awarded by the Department of the Navy Bureau of Medicine and Surgery to Becton, Dickinson And Company (BD) for maintenance services on a BD FACSCanto II flow cytometry instrument. The contract is a Firm Fixed Price Delivery Order issued under BD's Multiple Award Schedule (MAS) contract. The potential value of the contract is $15,019.32. This contract is not designated as a set-aside. BD is a global medical technology company that provides instruments,...
- Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, was awarded a $20,297.72 firm fixed-price delivery order by the Bureau of Medicine and Surgery (an element of the Department of Defense) on February 11, 2020, with an ultimate completion date of February 18, 2021. The contract covers service maintenance on a BD FACSCanto II flow cytometer (serial number V96101183), a sophisticated instrument used for cell analysis and research applications. The work will be...
- This federal contract award is for the maintenance of a FACSCANTO flow cytometer, an advanced cell analysis instrument, for the Bureau of Medicine and Surgery, a component of the Department of Defense. The $13,375.20 fixed-price purchase order was awarded to Becton, Dickinson and Company (BD), a prominent medical technology manufacturer, on March 30, 2015. The contract did not utilize a set-aside designation. BD is a leading provider of specialized medical equipment, reagents, and services to...
- Becton, Dickinson and Company (BD), operating through its BD Biosciences division, was awarded a delivery order for a FACSARIA 3 laser flow cytometry system valued at $23,180.04 on October 1, 2006, with completion targeted for September 30, 2007. The contract encompasses procurement and delivery of a three-laser flow cytometer with an integrated computer workstation, along with two years of preventive maintenance, software revisions, unlimited service visits, phone support, and reagents. The...
The Department of the Navy Bureau of Medicine and Surgery awarded Purchase Order number 343023 to Becton, Dickinson and Company BD Biosciences, Systems and Reagents Division for $15,000. The firm fixed price order is to provide a FACSCALIBUR 4 CLR flow cytometer with sort sensor unit and miscellaneous laboratory equipment, travel, and parts. Performance will take place in Silver Spring, Maryland from August 21-25, 2023. As the primary provider of medical services and materiel to the U.S. Navy and Marine Corps, the Bureau supports acquisition of specialized laboratory technologies like flow cytometers for medical research and analysis. No set aside designation or involvement of major subcontractors was indicated.
Generated 12/24/23, 12:42 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $0 | 9/5/23 | |
| Not listed | Not listed | $15.0k | 8/21/23 |